Esomeprazole

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

136 Suppliers, 65 USDMF, 47 CEP/COS, 6 JDMF, 39 EU WC, 79 KDMF, 45 NDC API, 66 Listed Suppliers

DEVELOPMENTS

3 Drug(s) in Development

3 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

15 Suppliers

15 Suppliers

DOSSIERs // Finished Dosage Forms

793 Dossiers, 92 FDA Orange Book, 359 Europe, 31 Canada, 86 Australia, 59 South Africa, 166 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE, DELAYED RELEASE;ORAL - EQ 20MG BASE, CAPSULE, DELAYED REL PELLETS;ORAL - EQ 20MG BASE, CAPSULE, DELAYED REL PELLETS;ORAL - EQ 40MG BASE, FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 2.5MG BASE/PACKET, FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 20MG BASE/PACKET, FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 40MG BASE/PACKET, FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 5MG BASE/PACKET, TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 30 BASF, 19 Kerry, 18 Roquette, 17 SPI Pharma, 15 Corel Pharma Chem, 14 Seppic, 13 Ideal Cures Pvt Ltd, 11 Gangwal Chemicals, 11 Microlex e.U, 10 Sigachi Industries, 10 Gangwal Healthcare, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 8 DKSH, 6 Actylis, 6 Lonza Capsugel, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 Nanjing Well Pharmaceutical, 4 Kima Chemical, 4 Prachin Chemical, 4 ACG Worldwide, 4 Ingredion Pharma Solutions, 3 Boai NKY Pharmaceuticals Ltd, 3 DFE Pharma, 3 The Dow Chemical Company, 3 Doshion Polyscience, 3 Vasa Pharmachem, 3 Jai Radhe Sales, 3 Pharmatrans-Sanaq, 2 Pfanstiehl, 2 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Ulanqab Kema New Material, 2 Seqens, 2 Finar, 2 Evonik, 2 Valens Pharmachem, 2 Qualicaps, 2 Alcedo Pharmachem, 1 Minakem, 1 Vertellus, 1 Aeon Procare, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 NEWEDGE Overseas, 1 Chynops Pharma, 1 Rochem International Inc

EXCIPIENTS BY APPLICATIONS

69 Coating Systems & Additives, 67 Fillers, Diluents & Binders, 43 Controlled & Modified Release, 33 Direct Compression, 30 Solubilizers, 30 Thickeners and Stabilizers, 26 Taste Masking, 24 Granulation, 23 Disintegrants & Superdisintegrants, 20 Lubricants & Glidants, 17 Chewable & Orodispersible Aids, 16 Topical, 16 Parenteral, 16 Film Formers & Plasticizers, 16 Co-Processed Excipients, 9 Empty Capsules, 8 Emulsifying Agents, 6 API Stability Enhancers, 5 Coloring Agents, 4 Rheology Modifiers, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 290 Finished Drug Prices

MARKET PLACE

65 APIs, 35 DOSSIERS // FDF

PATENTS

2 US Patents, 44 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 BioAnalytical Methods, 5 EDQM, 1 USP, 21 Others

DIGITAL CONTENT

15 Data Compilation & Company Tracker #PharmaFlow, 152 News

Information, Expiry & Status of Health Canada Patents covering Esomeprazole.

Esomeprazole

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

136 Suppliers

65 USDMF

47 CEP/COS

6 JDMF

39 EU WC

79 KDMF

45 NDC API

66 Listed Suppliers

DEVELOPMENTS

3 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

15 Suppliers

DOSSIERs // Finished Dosage Forms

793 Dossiers

92 FDA Orange Book

359 Europe

31 Canada

86 Australia

59 South Africa

166 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE, DELAYED RELEASE;ORAL - EQ 20MG BASE

CAPSULE, DELAYED REL PELLETS;ORAL - EQ 20MG BASE

CAPSULE, DELAYED REL PELLETS;ORAL - EQ 40MG BASE

FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 2.5MG BASE/PACKET

FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 20MG BASE/PACKET

FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 40MG BASE/PACKET

FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 5MG BASE/PACKET

TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

30 BASF

19 Kerry

18 Roquette

17 SPI Pharma

15 Corel Pharma Chem

14 Seppic

13 Ideal Cures Pvt Ltd

11 Gangwal Chemicals

11 Microlex e.U

10 Sigachi Industries

10 Gangwal Healthcare

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

8 DKSH

6 Actylis

6 Lonza Capsugel

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

4 Nanjing Well Pharmaceutical

4 Kima Chemical

4 Prachin Chemical

4 ACG Worldwide

4 Ingredion Pharma Solutions

3 Boai NKY Pharmaceuticals Ltd

3 DFE Pharma

3 The Dow Chemical Company

3 Doshion Polyscience

3 Vasa Pharmachem

3 Jai Radhe Sales

3 Pharmatrans-Sanaq

2 Pfanstiehl

2 Nanjing Bold Chemical

2 Nomisma Healthcare

2 Ulanqab Kema New Material

2 Seqens

2 Finar

2 Evonik

2 Valens Pharmachem

2 Qualicaps

TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;375MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons